APA (7th ed.) Citation

TH, T., & HSJ, K. (2026). Comparative Economic Evaluations of CAR-T Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review. PharmacoEconomics, 44(3), 287. https://doi.org/10.1007/s40273-025-01566-0

Chicago Style (17th ed.) Citation

TH, Tran, and Kim HSJ. "Comparative Economic Evaluations of CAR-T Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review." PharmacoEconomics 44, no. 3 (2026): 287. https://doi.org/10.1007/s40273-025-01566-0.

MLA (9th ed.) Citation

TH, Tran, and Kim HSJ. "Comparative Economic Evaluations of CAR-T Therapies for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Systematic Review." PharmacoEconomics, vol. 44, no. 3, 2026, p. 287, https://doi.org/10.1007/s40273-025-01566-0.